Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Agios Pharmaceuticals Receives Positive Orphan Designation for Mitapivat in Sickle Cell Disease from European Commission Quiver Quantitative, Inc. - Wed Dec 18, 4:20PM CST

Agios Pharmaceuticals announced the European Commission's orphan drug designation for mitapivat to treat sickle cell disease.Quiver AI SummaryAgios Pharmaceuticals has announced that the European Commission...

AGIO : 35.42 (-1.09%)
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease GlobeNewswire - Wed Dec 18, 6:00AM CST

AGIO : 35.42 (-1.09%)
Agios Pharmaceuticals Reports Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat for Transfusion-Dependent Thalassemia and Files for Regulatory Approval Quiver Quantitative, Inc. - Sun Dec 8, 9:54PM CST

Agios Pharmaceuticals reports positive outcomes from ENERGIZE-T study for mitapivat in transfusion-dependent thalassemia, seeking regulatory approval.Quiver AI SummaryAgios Pharmaceuticals announced the...

AGIO : 35.42 (-1.09%)
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat GlobeNewswire - Sun Dec 8, 11:40AM CST

AGIO : 35.42 (-1.09%)
Are Options Traders Betting on a Big Move in Agios (AGIO) Stock?
Are Options Traders Betting on a Big Move in Agios (AGIO) Stock? Zacks Investment Research - Thu Dec 5, 8:50AM CST

Investors in Agios Pharmaceuticals, Inc. AGIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $17.50 Put had some of the highest implied...

AGIO : 35.42 (-1.09%)
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition GlobeNewswire - Tue Nov 5, 8:05AM CST

AGIO : 35.42 (-1.09%)
Agios Pharmaceuticals: Q3 Earnings Snapshot AP - Thu Oct 31, 5:42AM CDT

Agios Pharmaceuticals: Q3 Earnings Snapshot

AGIO : 35.42 (-1.09%)
Agios Reports Business Highlights and Third Quarter 2024 Financial Results GlobeNewswire - Thu Oct 31, 5:30AM CDT

AGIO : 35.42 (-1.09%)
Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease GlobeNewswire - Wed Oct 23, 6:00AM CDT

AGIO : 35.42 (-1.09%)
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 GlobeNewswire - Thu Oct 17, 6:00AM CDT

AGIO : 35.42 (-1.09%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot